1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Lung Cancer Liquid Biops Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Exosomes and RNA 1.2.3 CTCs and ctDNA 1.3 Market by Application 1.3.1 Global Lung Cancer Liquid Biops Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals and Clinics 1.3.3 Physicians'Office Laboratories 1.3.4 Clinical Diagnostic Laboratories 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Lung Cancer Liquid Biops Market Perspective (2016-2027) 2.2 Lung Cancer Liquid Biops Growth Trends by Regions 2.2.1 Lung Cancer Liquid Biops Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Lung Cancer Liquid Biops Historic Market Share by Regions (2016-2021) 2.2.3 Lung Cancer Liquid Biops Forecasted Market Size by Regions (2022-2027) 2.3 Lung Cancer Liquid Biops Industry Dynamic 2.3.1 Lung Cancer Liquid Biops Market Trends 2.3.2 Lung Cancer Liquid Biops Market Drivers 2.3.3 Lung Cancer Liquid Biops Market Challenges 2.3.4 Lung Cancer Liquid Biops Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Lung Cancer Liquid Biops Players by Revenue 3.1.1 Global Top Lung Cancer Liquid Biops Players by Revenue (2016-2021) 3.1.2 Global Lung Cancer Liquid Biops Revenue Market Share by Players (2016-2021) 3.2 Global Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Lung Cancer Liquid Biops Revenue 3.4 Global Lung Cancer Liquid Biops Market Concentration Ratio 3.4.1 Global Lung Cancer Liquid Biops Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biops Revenue in 2020 3.5 Lung Cancer Liquid Biops Key Players Head office and Area Served 3.6 Key Players Lung Cancer Liquid Biops Product Solution and Service 3.7 Date of Enter into Lung Cancer Liquid Biops Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Lung Cancer Liquid Biops Breakdown Data by Type 4.1 Global Lung Cancer Liquid Biops Historic Market Size by Type (2016-2021) 4.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2022-2027) 5 Lung Cancer Liquid Biops Breakdown Data by Application 5.1 Global Lung Cancer Liquid Biops Historic Market Size by Application (2016-2021) 5.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Lung Cancer Liquid Biops Market Size (2016-2027) 6.2 North America Lung Cancer Liquid Biops Market Size by Type 6.2.1 North America Lung Cancer Liquid Biops Market Size by Type (2016-2021) 6.2.2 North America Lung Cancer Liquid Biops Market Size by Type (2022-2027) 6.2.3 North America Lung Cancer Liquid Biops Market Size by Type (2016-2027) 6.3 North America Lung Cancer Liquid Biops Market Size by Application 6.3.1 North America Lung Cancer Liquid Biops Market Size by Application (2016-2021) 6.3.2 North America Lung Cancer Liquid Biops Market Size by Application (2022-2027) 6.3.3 North America Lung Cancer Liquid Biops Market Size by Application (2016-2027) 6.4 North America Lung Cancer Liquid Biops Market Size by Country 6.4.1 North America Lung Cancer Liquid Biops Market Size by Country (2016-2021) 6.4.2 North America Lung Cancer Liquid Biops Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Lung Cancer Liquid Biops Market Size (2016-2027) 7.2 Europe Lung Cancer Liquid Biops Market Size by Type 7.2.1 Europe Lung Cancer Liquid Biops Market Size by Type (2016-2021) 7.2.2 Europe Lung Cancer Liquid Biops Market Size by Type (2022-2027) 7.2.3 Europe Lung Cancer Liquid Biops Market Size by Type (2016-2027) 7.3 Europe Lung Cancer Liquid Biops Market Size by Application 7.3.1 Europe Lung Cancer Liquid Biops Market Size by Application (2016-2021) 7.3.2 Europe Lung Cancer Liquid Biops Market Size by Application (2022-2027) 7.3.3 Europe Lung Cancer Liquid Biops Market Size by Application (2016-2027) 7.4 Europe Lung Cancer Liquid Biops Market Size by Country 7.4.1 Europe Lung Cancer Liquid Biops Market Size by Country (2016-2021) 7.4.2 Europe Lung Cancer Liquid Biops Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Lung Cancer Liquid Biops Market Size (2016-2027) 8.2 Asia-Pacific Lung Cancer Liquid Biops Market Size by Type 8.2.1 Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2016-2027) 8.3 Asia-Pacific Lung Cancer Liquid Biops Market Size by Application 8.3.1 Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2016-2027) 8.4 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region 8.4.1 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Lung Cancer Liquid Biops Market Size (2016-2027) 9.2 Latin America Lung Cancer Liquid Biops Market Size by Type 9.2.1 Latin America Lung Cancer Liquid Biops Market Size by Type (2016-2021) 9.2.2 Latin America Lung Cancer Liquid Biops Market Size by Type (2022-2027) 9.2.3 Latin America Lung Cancer Liquid Biops Market Size by Type (2016-2027) 9.3 Latin America Lung Cancer Liquid Biops Market Size by Application 9.3.1 Latin America Lung Cancer Liquid Biops Market Size by Application (2016-2021) 9.3.2 Latin America Lung Cancer Liquid Biops Market Size by Application (2022-2027) 9.3.3 Latin America Lung Cancer Liquid Biops Market Size by Application (2016-2027) 9.4 Latin America Lung Cancer Liquid Biops Market Size by Country 9.4.1 Latin America Lung Cancer Liquid Biops Market Size by Country (2016-2021) 9.4.2 Latin America Lung Cancer Liquid Biops Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Lung Cancer Liquid Biops Market Size (2016-2027) 10.2 Middle East & Africa Lung Cancer Liquid Biops Market Size by Type 10.2.1 Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2016-2027) 10.3 Middle East & Africa Lung Cancer Liquid Biops Market Size by Application 10.3.1 Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2016-2027) 10.4 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country 10.4.1 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Biocept 11.1.1 Biocept Company Details 11.1.2 Biocept Business Overview 11.1.3 Biocept Lung Cancer Liquid Biops Introduction 11.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.1.5 Biocept Recent Development 11.2 EntroGen 11.2.1 EntroGen Company Details 11.2.2 EntroGen Business Overview 11.2.3 EntroGen Lung Cancer Liquid Biops Introduction 11.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.2.5 EntroGen Recent Development 11.3 Cynvenio Biosystems 11.3.1 Cynvenio Biosystems Company Details 11.3.2 Cynvenio Biosystems Business Overview 11.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Introduction 11.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.3.5 Cynvenio Biosystems Recent Development 11.4 Exosome Diagnostics 11.4.1 Exosome Diagnostics Company Details 11.4.2 Exosome Diagnostics Business Overview 11.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Introduction 11.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.4.5 Exosome Diagnostics Recent Development 11.5 F. Hoffmann-La Roche 11.5.1 F. Hoffmann-La Roche Company Details 11.5.2 F. Hoffmann-La Roche Business Overview 11.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Introduction 11.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.5.5 F. Hoffmann-La Roche Recent Development 11.6 Clearbridge BioMedics 11.6.1 Clearbridge BioMedics Company Details 11.6.2 Clearbridge BioMedics Business Overview 11.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Introduction 11.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.6.5 Clearbridge BioMedics Recent Development 11.7 Bio-Rad Laboratories 11.7.1 Bio-Rad Laboratories Company Details 11.7.2 Bio-Rad Laboratories Business Overview 11.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Introduction 11.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.7.5 Bio-Rad Laboratories Recent Development 11.8 Agena Bioscience 11.8.1 Agena Bioscience Company Details 11.8.2 Agena Bioscience Business Overview 11.8.3 Agena Bioscience Lung Cancer Liquid Biops Introduction 11.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.8.5 Agena Bioscience Recent Development 11.9 Cancer Genetics 11.9.1 Cancer Genetics Company Details 11.9.2 Cancer Genetics Business Overview 11.9.3 Cancer Genetics Lung Cancer Liquid Biops Introduction 11.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.9.5 Cancer Genetics Recent Development 11.10 CellMax Life 11.10.1 CellMax Life Company Details 11.10.2 CellMax Life Business Overview 11.10.3 CellMax Life Lung Cancer Liquid Biops Introduction 11.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.10.5 CellMax Life Recent Development 11.11 Nateras 11.11.1 Nateras Company Details 11.11.2 Nateras Business Overview 11.11.3 Nateras Lung Cancer Liquid Biops Introduction 11.11.4 Nateras Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.11.5 Nateras Recent Development 11.12 MedGenome 11.12.1 MedGenome Company Details 11.12.2 MedGenome Business Overview 11.12.3 MedGenome Lung Cancer Liquid Biops Introduction 11.12.4 MedGenome Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.12.5 MedGenome Recent Development 11.13 OncoDNA 11.13.1 OncoDNA Company Details 11.13.2 OncoDNA Business Overview 11.13.3 OncoDNA Lung Cancer Liquid Biops Introduction 11.13.4 OncoDNA Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.13.5 OncoDNA Recent Development 11.14 Genomic Health 11.14.1 Genomic Health Company Details 11.14.2 Genomic Health Business Overview 11.14.3 Genomic Health Lung Cancer Liquid Biops Introduction 11.14.4 Genomic Health Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.14.5 Genomic Health Recent Development 11.15 Trovagene 11.15.1 Trovagene Company Details 11.15.2 Trovagene Business Overview 11.15.3 Trovagene Lung Cancer Liquid Biops Introduction 11.15.4 Trovagene Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.15.5 Trovagene Recent Development 11.16 Fluxion Biosciences 11.16.1 Fluxion Biosciences Company Details 11.16.2 Fluxion Biosciences Business Overview 11.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Introduction 11.16.4 Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.16.5 Fluxion Biosciences Recent Development 11.17 Biodesix 11.17.1 Biodesix Company Details 11.17.2 Biodesix Business Overview 11.17.3 Biodesix Lung Cancer Liquid Biops Introduction 11.17.4 Biodesix Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.17.5 Biodesix Recent Development 11.18 Epic Sciences 11.18.1 Epic Sciences Company Details 11.18.2 Epic Sciences Business Overview 11.18.3 Epic Sciences Lung Cancer Liquid Biops Introduction 11.18.4 Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.18.5 Epic Sciences Recent Development 11.18 Shuwen Biotech .1 Shuwen Biotech Company Details .2 Shuwen Biotech Business Overview .3 Shuwen Biotech Lung Cancer Liquid Biops Introduction .4 Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2016-2021) .5 Shuwen Biotech Recent Development 11.20 Personal Genome Diagnostics 11.20.1 Personal Genome Diagnostics Company Details 11.20.2 Personal Genome Diagnostics Business Overview 11.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Introduction 11.20.4 Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.20.5 Personal Genome Diagnostics Recent Development 11.21 Predicine 11.21.1 Predicine Company Details 11.21.2 Predicine Business Overview 11.21.3 Predicine Lung Cancer Liquid Biops Introduction 11.21.4 Predicine Revenue in Lung Cancer Liquid Biops Business (2016-2021) 11.21.5 Predicine Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Lung Cancer Liquid Biops Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Exosomes and RNA Table 3. Key Players of CTCs and ctDNA Table 4. Global Lung Cancer Liquid Biops Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Lung Cancer Liquid Biops Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Lung Cancer Liquid Biops Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Lung Cancer Liquid Biops Market Share by Regions (2016-2021) Table 8. Global Lung Cancer Liquid Biops Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Lung Cancer Liquid Biops Market Share by Regions (2022-2027) Table 10. Lung Cancer Liquid Biops Market Trends Table 11. Lung Cancer Liquid Biops Market Drivers Table 12. Lung Cancer Liquid Biops Market Challenges Table 13. Lung Cancer Liquid Biops Market Restraints Table 14. Global Lung Cancer Liquid Biops Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Lung Cancer Liquid Biops Market Share by Players (2016-2021) Table 16. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biops as of 2020) Table 17. Ranking of Global Top Lung Cancer Liquid Biops Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Lung Cancer Liquid Biops Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Lung Cancer Liquid Biops Product Solution and Service Table 21. Date of Enter into Lung Cancer Liquid Biops Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million) Table 24. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2016-2021) Table 25. Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Lung Cancer Liquid Biops Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Lung Cancer Liquid Biops Revenue Market Share by Application (2016-2021) Table 29. Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Lung Cancer Liquid Biops Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million) Table 32. North America Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million) Table 34. North America Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Lung Cancer Liquid Biops Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Lung Cancer Liquid Biops Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Lung Cancer Liquid Biops Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Lung Cancer Liquid Biops Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Lung Cancer Liquid Biops Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Lung Cancer Liquid Biops Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Lung Cancer Liquid Biops Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Lung Cancer Liquid Biops Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2022-2027) & (US$ Million) Table 61. Biocept Company Details Table 62. Biocept Business Overview Table 63. Biocept Lung Cancer Liquid Biops Product Table 64. Biocept Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 65. Biocept Recent Development Table 66. EntroGen Company Details Table 67. EntroGen Business Overview Table 68. EntroGen Lung Cancer Liquid Biops Product Table 69. EntroGen Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 70. EntroGen Recent Development Table 71. Cynvenio Biosystems Company Details Table 72. Cynvenio Biosystems Business Overview Table 73. Cynvenio Biosystems Lung Cancer Liquid Biops Product Table 74. Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 75. Cynvenio Biosystems Recent Development Table 76. Exosome Diagnostics Company Details Table 77. Exosome Diagnostics Business Overview Table 78. Exosome Diagnostics Lung Cancer Liquid Biops Product Table 79. Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 80. Exosome Diagnostics Recent Development Table 81. F. Hoffmann-La Roche Company Details Table 82. F. Hoffmann-La Roche Business Overview Table 83. F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Table 84. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 85. F. Hoffmann-La Roche Recent Development Table 86. Clearbridge BioMedics Company Details Table 87. Clearbridge BioMedics Business Overview Table 88. Clearbridge BioMedics Lung Cancer Liquid Biops Product Table 89. Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 90. Clearbridge BioMedics Recent Development Table 91. Bio-Rad Laboratories Company Details Table 92. Bio-Rad Laboratories Business Overview Table 93. Bio-Rad Laboratories Lung Cancer Liquid Biops Product Table 94. Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 95. Bio-Rad Laboratories Recent Development Table 96. Agena Bioscience Company Details Table 97. Agena Bioscience Business Overview Table 98. Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 99. Agena Bioscience Recent Development Table 100. Cancer Genetics Company Details Table 101. Cancer Genetics Business Overview Table 102. Cancer Genetics Lung Cancer Liquid Biops Product Table 103. Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 104. Cancer Genetics Recent Development Table 105. CellMax Life Company Details Table 106. CellMax Life Business Overview Table 107. CellMax Life Lung Cancer Liquid Biops Product Table 108. CellMax Life Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 109. CellMax Life Recent Development Table 110. Nateras Company Details Table 111. Nateras Business Overview Table 112. Nateras Lung Cancer Liquid Biops Product Table 113. Nateras Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 114. Nateras Recent Development Table 115. MedGenome Company Details Table 116. MedGenome Business Overview Table 117. MedGenome Lung Cancer Liquid Biops Product Table 118. MedGenome Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 119. MedGenome Recent Development Table 120. OncoDNA Company Details Table 121. OncoDNA Business Overview Table 122. OncoDNA Lung Cancer Liquid Biops Product Table 123. OncoDNA Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 124. OncoDNA Recent Development Table 125. Genomic Health Company Details Table 126. Genomic Health Business Overview Table 127. Genomic Health Lung Cancer Liquid Biops Product Table 128. Genomic Health Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 129. Genomic Health Recent Development Table 130. Trovagene Company Details Table 131. Trovagene Business Overview Table 132. Trovagene Lung Cancer Liquid Biops Product Table 133. Trovagene Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 134. Trovagene Recent Development Table 135. Fluxion Biosciences Company Details Table 136. Fluxion Biosciences Business Overview Table 137. Fluxion Biosciences Lung Cancer Liquid Biops Product Table 138. Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 139. Fluxion Biosciences Recent Development Table 140. Biodesix Company Details Table 141. Biodesix Business Overview Table 142. Biodesix Lung Cancer Liquid Biops Product Table 143. Biodesix Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 144. Biodesix Recent Development Table 145. Epic Sciences Company Details Table 146. Epic Sciences Business Overview Table 147. Epic Sciences Lung Cancer Liquid Biops Product Table 148. Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 149. Epic Sciences Recent Development Table 150. Shuwen Biotech Company Details Table 151. Shuwen Biotech Business Overview Table 152. Shuwen Biotech Lung Cancer Liquid Biops Product Table 153. Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 154. Shuwen Biotech Recent Development Table 155. Personal Genome Diagnostics Company Details Table 156. Personal Genome Diagnostics Business Overview Table 157. Personal Genome Diagnostics Lung Cancer Liquid Biops Product Table 158. Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 159. Personal Genome Diagnostics Recent Development Table 160. Predicine Company Details Table 161. Predicine Business Overview Table 162. Predicine Lung Cancer Liquid Biops Product Table 163. Predicine Revenue in Lung Cancer Liquid Biops Business (2016-2021) & (US$ Million) Table 164. Predicine Recent Development Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Global Lung Cancer Liquid Biops Market Share by Type: 2020 VS 2027 Figure 2. Exosomes and RNA Features Figure 3. CTCs and ctDNA Features Figure 4. Global Lung Cancer Liquid Biops Market Share by Application: 2020 VS 2027 Figure 5. Hospitals and Clinics Case Studies Figure 6. Physicians'Office Laboratories Case Studies Figure 7. Clinical Diagnostic Laboratories Case Studies Figure 8. Lung Cancer Liquid Biops Report Years Considered Figure 9. Global Lung Cancer Liquid Biops Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Lung Cancer Liquid Biops Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Lung Cancer Liquid Biops Market Share by Regions: 2020 VS 2027 Figure 12. Global Lung Cancer Liquid Biops Market Share by Regions (2022-2027) Figure 13. Global Lung Cancer Liquid Biops Market Share by Players in 2020 Figure 14. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Liquid Biops as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biops Revenue in 2020 Figure 16. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2016-2021) Figure 17. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2022-2027) Figure 18. North America Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Lung Cancer Liquid Biops Market Share by Type (2016-2027) Figure 20. North America Lung Cancer Liquid Biops Market Share by Application (2016-2027) Figure 21. North America Lung Cancer Liquid Biops Market Share by Country (2016-2027) Figure 22. United States Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Lung Cancer Liquid Biops Market Share by Type (2016-2027) Figure 26. Europe Lung Cancer Liquid Biops Market Share by Application (2016-2027) Figure 27. Europe Lung Cancer Liquid Biops Market Share by Country (2016-2027) Figure 28. Germany Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Lung Cancer Liquid Biops Market Share by Type (2016-2027) Figure 36. Asia-Pacific Lung Cancer Liquid Biops Market Share by Application (2016-2027) Figure 37. Asia-Pacific Lung Cancer Liquid Biops Market Share by Region (2016-2027) Figure 38. China Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Lung Cancer Liquid Biops Market Share by Type (2016-2027) Figure 46. Latin America Lung Cancer Liquid Biops Market Share by Application (2016-2027) Figure 47. Latin America Lung Cancer Liquid Biops Market Share by Country (2016-2027) Figure 48. Mexico Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Lung Cancer Liquid Biops Market Share by Type (2016-2027) Figure 52. Middle East & Africa Lung Cancer Liquid Biops Market Share by Application (2016-2027) Figure 53. Middle East & Africa Lung Cancer Liquid Biops Market Share by Country (2016-2027) Figure 54. Turkey Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Lung Cancer Liquid Biops Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Biocept Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 58. EntroGen Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 59. Cynvenio Biosystems Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 60. Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 62. Clearbridge BioMedics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 63. Bio-Rad Laboratories Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 64. Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 65. Cancer Genetics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 66. CellMax Life Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 67. Nateras Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 68. MedGenome Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 69. OncoDNA Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 70. Genomic Health Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 71. Trovagene Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 72. Fluxion Biosciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 73. Biodesix Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 74. Epic Sciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 75. Shuwen Biotech Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 76. Personal Genome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 77. Predicine Revenue Growth Rate in Lung Cancer Liquid Biops Business (2016-2021) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Biocept EntroGen Cynvenio Biosystems Exosome Diagnostics F. Hoffmann-La Roche Clearbridge BioMedics Bio-Rad Laboratories Agena Bioscience Cancer Genetics CellMax Life Nateras MedGenome OncoDNA Genomic Health Trovagene Fluxion Biosciences Biodesix Epic Sciences Shuwen Biotech Personal Genome Diagnostics Predicine